Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Post-Market Clinical Follow-Up Study of the Solo+ Tympanostomy Tube Device

NCT: NCT07029997 · RECRUITING

NCT IDNCT07029997
StatusRECRUITING
Start Date2026-05-21
Completion2030-05
SponsorAventaMed DAC (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this project is to collect information from the doctor notes about the use of the device, to monitor the tubes after surgery, and collect information from patients and parents/guardians about their views on the procedure. Since the device became available in Europe, it is important to collect information from both patients planned for the procedure (prospective) and those who already underwent the procedure (retrospective) to have collect as much data as possible.

Frequently Asked Questions

What is Post-Market Clinical Follow-Up Study of the Solo+ Tympanostomy Tube Device?

Post-Market Clinical Follow-Up Study of the Solo+ Tympanostomy Tube Device is a clinical trial registered under NCT07029997. Current status: RECRUITING.

What is the status of NCT07029997?

The current status of NCT07029997 (Post-Market Clinical Follow-Up Study of the Solo+ Tympanostomy Tube Device) is: RECRUITING.

When did Post-Market Clinical Follow-Up Study of the Solo+ Tympanostomy Tube Device start?

Post-Market Clinical Follow-Up Study of the Solo+ Tympanostomy Tube Device started on 2026-05-21.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.